← Back to all recalls
DRUG RECALLMODERATE
Octreotide Acetate Injectable Suspension 30 mg
Teva is recalling Octreotide Acetate 30 mg injectable suspension kits (NDC 0480-9262-08) due to sterility assurance concerns from manufacturing deficiencies.
What to do
Do not use this medication. Contact your pharmacy or healthcare provider immediately to obtain a replacement or alternative treatment. Return the recalled product to your pharmacy for proper disposal.
Why it was recalled
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
How to identify it
UPC 45011002
Where it was sold
Distributed in US.
Official source
Other recent recalls from Teva Pharmaceuticals USA, Inc
Editorial summary by Recall Canary · last updated 2026-05-06 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification